Sort by
Refine Your Search
-
sensitivity genomic tools for the characterization of measurable residual disease (MRD) in patients with AML to predict and prevent relapse. This work includes multiple governmental and private sector
Enter an email to receive alerts for programming-"Multiple"-"U"-"Prof"-"U.S" positions